The novel treatment of tirzepatide peptide represents a major advance in the care of type 2 diabetes. Different to existing therapies, tirzepatide affects two pathways – the GLP-1 hormone and GIP – leading to https://tirzepatide-peptide227258.qowap.com/101073322/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment